Medtronic PLC (MDT)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$97.76
Buy
$97.81
$-0.78 (-0.79%)
Prices updated at 16 Dec 2025, 15:23 EST
| Prices minimum 15 mins delay
Prices in USD
Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 32,364m | 33,537m | |
| 21,148m | 21,905m | |
| 5,520m | 6,540m | |
| 17.06 | 19.50 | |
| 3,676m | 4,662m | |
| 8,203m | 9,218m | |
| Sales, General and administrative | 10,736m | 10,849m |
| Interest expenses | 719m | 729m |
| Provision for income taxes | 1,133m | 936m |
| Operating expenses | 15,628m | 15,365m |
| Income before taxes | 4,837m | 5,628m |
| Net income available to common shareholders | 3,676m | 4,662m |
| 3.28 | 3.72 | |
| Net interest income | -719m | -729m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 3.27 | 3.69 |
| Free cash flow per share | 4.1975 | 4.0438 |
| Book value/share | 37.8184 | 37.9497 |
| Debt equity ratio | 0.4766 | 0.533941 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 21,935m | 23,814m |
| Current liabilities | 10,789m | 12,879m |
| Total capital | 74,091m | 73,614m |
| Total debt | 25,024m | 28,516m |
| Total equity | 50,214m | 48,024m |
| Total non current liabilities | - | - |
| Loans | 23,877m | 25,590m |
| Total assets | 89,981m | 91,680m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,284m | 2,218m |
| Common stock | 1,311m | 1,282m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 1,543m | 1,284m |
| Cash dividends paid | -3,666m | -3,589m |
| 5,200m | 5,185m | |
| Investments (gains) losses | -2,366m | -1,937m |
| 1,284m | 2,218m | |
| Net income | - | - |
| 6,787m | 7,044m | |
| -1,587m | -1,859m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.